Guanze Medical Information Industry (Holding) Co., Ltd. (HKG:2427)
Hong Kong · Delayed Price · Currency is HKD 2.650
+0.260 (10.88%)
Sep 11, 2026, 4:08 PM HKT
HKG:2427 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 85.02 | 88.45 | 155.74 | 156.07 | 177.11 | 211.08 | |
Revenue Growth | -42.38% | -43.21% | -0.21% | -11.88% | -16.09% | 14.45% |
Cost of Revenue | 74.49 | 66.32 | 92.95 | 70.67 | 96.14 | 135.38 |
Gross Profit | 10.54 | 22.13 | 62.79 | 85.41 | 80.98 | 75.7 |
Selling, General & Admin | 41.54 | 34.23 | 31.57 | 40.9 | 32.55 | 33.19 |
Research & Development | 26.65 | 5.79 | 4.07 | 1.53 | 0.54 | 0.4 |
Operating Expenses | 73.13 | 43.84 | 38.83 | 46.7 | 33.29 | 33.51 |
Operating Income | -62.59 | -21.72 | 23.95 | 38.7 | 47.68 | 42.19 |
Interest Expense | -0.42 | -0.52 | -0.71 | -0.86 | -1.03 | -0.6 |
Interest & Investment Income | 0.01 | 0.06 | 0.72 | 0.84 | 0.03 | 0.04 |
Currency Exchange Gain (Loss) | -0.3 | -0.31 | 0.3 | - | - | - |
Other Non Operating Income (Expenses) | -6.62 | -3.84 | 2.05 | -0.03 | 1.7 | 1.03 |
EBT Excluding Unusual Items | -69.92 | -26.31 | 26.31 | 38.65 | 48.38 | 42.66 |
Asset Writedown | -5.07 | -5.07 | - | - | - | - |
Other Unusual Items | 0 | 0.01 | - | - | -18.42 | -9.6 |
Pretax Income | -76.65 | -31.38 | 26.31 | 38.65 | 29.96 | 33.06 |
Income Tax Expense | -4.12 | -1.42 | 8.86 | 10.73 | 11.68 | 9.99 |
Earnings From Continuing Operations | -72.53 | -29.96 | 17.45 | 27.92 | 18.29 | 23.07 |
Minority Interest in Earnings | 0.64 | 0.25 | -0.25 | -0.36 | -0.34 | -0.13 |
Net Income | -71.89 | -29.72 | 17.2 | 27.57 | 17.94 | 22.94 |
Net Income to Common | -71.89 | -29.72 | 17.2 | 27.57 | 17.94 | 22.94 |
Net Income Growth | - | - | -37.59% | 53.63% | -21.76% | -21.03% |
Shares Outstanding (Basic) | 941 | 936 | 939 | 950 | 766 | 757 |
Shares Outstanding (Diluted) | 941 | 936 | 939 | 950 | 766 | 757 |
Shares Change | -0.54% | -0.35% | -1.12% | 24.00% | 1.19% | - |
EPS (Basic) | -0.08 | -0.03 | 0.02 | 0.03 | 0.02 | 0.03 |
EPS (Diluted) | -0.08 | -0.03 | 0.02 | 0.03 | 0.02 | 0.03 |
EPS Growth | - | - | -36.89% | 23.89% | -22.68% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | -9.15 | -5.56 | 1.54 | -0.01 | -4.72 |
Free Cash Flow Per Share | - | -0.01 | -0.01 | 0.00 | - | -0.01 |
Dividend Per Share | - | - | - | 0.019 | 0.019 | - |
Dividend Growth | - | - | - | 2.62% | - | - |
Gross Margin | 12.39% | 25.02% | 40.31% | 54.72% | 45.72% | 35.86% |
Operating Margin | -73.62% | -24.55% | 15.38% | 24.80% | 26.92% | 19.99% |
Profit Margin | -84.55% | -33.60% | 11.05% | 17.66% | 10.13% | 10.87% |
Free Cash Flow Margin | - | -10.35% | -3.57% | 0.99% | -0.01% | -2.23% |
EBITDA | -44.68 | -7.68 | 30.52 | 44.34 | 51.85 | 45.46 |
EBITDA Margin | -52.55% | -8.68% | 19.59% | 28.41% | 29.28% | 21.54% |
D&A For EBITDA | 17.91 | 14.04 | 6.56 | 5.64 | 4.17 | 3.28 |
EBIT | -62.59 | -21.72 | 23.95 | 38.7 | 47.68 | 42.19 |
EBIT Margin | -73.62% | -24.55% | 15.38% | 24.80% | 26.92% | 19.99% |
Effective Tax Rate | - | - | 33.67% | 27.76% | 38.97% | 30.22% |